Withdrawal Notice
This paper was originally published in Oncotarget Advance Online Publications on 08/10/2019.In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.
Meta-Analysis:
Prognostic role of anti-diabetic drugs in pancreatic cancer: A systematic review and meta-analysis
Lei Zheng1,*, Shinan Yin1,*, Fenghua Yao2, Hua Bai1 and Danqing Jing1
1Department of Endocrinology, the First Affiliated Hospital of Chinese PLA General Hospital, Beijing, China
2Department of Nephrology, the First Hospital Affiliated to the Chinese PLA General Hospital, Beijing, China
*These authors contributed equally to this work
Correspondence to:
Shinan Yin, email: [email protected]
Keywords: anti-diabetic drug(ADD), metformin, pancreatic cancer, prognosis
Received: March 31, 2017 Accepted: April 27, 2017 Published: May 09, 2017
![Creative Commons License](/images/80x15.png)
PII: 17755